T. Maiti, und V. Pradhan. Statistical methods in medical research, 17 (6):
621-34(Dezember 2008)5470<m:linebreak></m:linebreak>JID: 9212457; 2008/03/28 aheadofprint; 2008/04/03 aheadofprint; 2008/04/15 aheadofprint; ppublish;<m:linebreak></m:linebreak>Regressió logística.
S. Geneletti, S. Richardson, und N. Best. Biostatistics (Oxford, England), 10 (1):
17-31(Januar 2009)4716<m:linebreak></m:linebreak>GR: Department of Health/United Kingdom; JID: 100897327; 2008/05/14 aheadofprint; ppublish;.
S. Samuelsen, und G. Eide. Statistics in medicine, 27 (9):
1447-67(April 2008)4992<m:linebreak></m:linebreak>CI: 2008; JID: 8215016; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
Y. Chen, C. Hu, und Y. Wang. Biostatistics (Oxford, England), 7 (4):
515-29(Oktober 2006)5077<m:linebreak></m:linebreak>JID: 100897327; 2006/02/14 aheadofprint; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.
N. Dendukuri, E. Rahme, P. Bélisle, und L. Joseph. Biometrics, 60 (2):
388-97(Juni 2004)5555<m:linebreak></m:linebreak>JID: 0370625; ppublish;<m:linebreak></m:linebreak>Proves diagnòstiques; Sample size.
M. Kramer, und A. Feinstein. Clinical pharmacology and therapeutics, 29 (1):
111-23(Januar 1981)2975<m:linebreak></m:linebreak>Mesures de concordància.
Y. Chi, und C. Chen. Statistics in medicine, 27 (29):
6175-89(Dezember 2008)5263<m:linebreak></m:linebreak>LR: 20090730; JID: 8215016; 0 (Antineoplastic Agents); 33419-42-0 (Etoposide); ppublish;<m:linebreak></m:linebreak>Fase II.